Digital health is attracting capital again, but investors are becoming more selective about what deserves it.
US digital-health companies raised $7.4 billion across 244 deals in H1 2026, up from $6.4 billion across 245 deals in H1 2025. Yet 45% of the capital went into deals of $100 million or more, showing that funding is concentrating around companies that can demonstrate a stronger path to scale.
The issue is no longer whether healthcare organizations will adopt digital tools, but which models can turn adoption into repeatable revenue, clinical value and expansion across customers or markets.
Which Digital Health Models Have the Strongest Scaling Potential?
Digital health is not one commercial category. The economics differ significantly between virtual care, clinical workflow software, remote monitoring, digital therapeutics, consumer health platforms and data infrastructure.
A useful way to distinguish them is by their relationship with the healthcare system:
- Clinical workflow: Embedded into provider operations and can create recurring enterprise revenue.
- Remote monitoring: Can generate ongoing value where reimbursement and clinical workflows support continued use.
- Virtual care: Large addressable demand, but economics depend heavily on utilization, reimbursement and provider capacity.
- Digital therapeutics: Potentially defensible where clinical evidence and reimbursement support adoption, but regulatory and evidence requirements can lengthen commercialization.
- Consumer health: Can scale rapidly when engagement is strong, but customer acquisition and retention can make unit economics difficult.
- Data and infrastructure: Often less visible to patients but can become deeply embedded across healthcare organizations.
User adoption is only one measure of scalability. The stronger models have a clear buyer, recurring use and a reason for the customer to continue paying.
Nexdigm Tests Whether Adoption Can Become a Business Model
Nexdigm evaluates digital-health opportunities by looking beyond adoption rates to the underlying commercial mechanics.
The assessment starts with a basic question: who receives the value and who pays for it?
A product used by thousands of patients may have limited commercial potential if no stakeholder has a sustainable payment mechanism.
Conversely, a workflow solution with a smaller user base can become highly scalable if it solves a recurring operational problem for hospitals or payers.
Nexdigm therefore assesses the relationship between:
- User
- Buyer
- Economic value
- Payment mechanism
- Expansion potential
This separates engagement from commercial traction,
which is increasingly important as digital-health investment becomes more concentrated.
Three Tests Separate Adoption from Scalability
The economic test
A scalable model needs recurring economic value. This could mean reducing administrative workload, increasing provider capacity, improving patient retention or generating reimbursable clinical activity.
The key indicators include:
- Recurring revenue
- Customer retention
- Acquisition cost
- Revenue per customer
- Contract expansion
- Reimbursement visibility
The clinical test
Digital health cannot scale indefinitely if clinicians regard it as additional work.
Interoperability, workflow fit, clinical evidence and ease of use therefore matter. WHO identifies interoperability and data sharing as important foundations for scaling digital-health solutions.
The expansion test
A model that works in one hospital may not automatically work across 100.
Expansion can be constrained by different EHR systems, regulatory requirements, reimbursement structures, procurement processes and clinical workflows. The strongest models are designed around a repeatable implementation pathway rather than a highly customized deployment for every customer.
Regulation Is Part of the Commercial Model
Regulation can determine both the addressable market and the cost of reaching it.
A digital-health product may face very different requirements depending on whether it is a wellness application, clinical decision-support tool, medical device or regulated software product. Data privacy, cybersecurity and interoperability requirements can also affect implementation.
India provides a useful example of how digital infrastructure can influence scalability.
By February 2025, the Ayushman Bharat Digital Mission had more than 73.98 crore ABHA accounts, 49.06 crore linked health records and 3.63 lakh registered health facilities.
For companies entering such markets, the relevant question is whether the surrounding health infrastructure allows the product to integrate and scale.
How Nexdigm Assesses Digital Health Market Potential
Nexdigm evaluates digital-health models through five dimensions:
- Market & Use-Case Attractiveness
Assess demand by application, customer segment, care setting and geography to identify where the underlying need is strongest. - Buyer & Adoption Readiness
Map patients, providers, payers and enterprises to determine who uses the product, who pays and what barriers could slow adoption. - Monetization & Economics
Evaluate pricing, reimbursement, contract structures, customer acquisition, retention and recurring revenue potential. - Regulatory & Clinical Integration
Assess regulatory classification, evidence requirements, interoperability, data governance and workflow integration. - Scalability & Market Prioritization
Compare markets and business models based on adoption potential, implementation complexity, competitive intensity and commercial scalability.
The framework helps companies determine which models to scale, which markets to enter and where additional validation is required before investment.
Nexdigm’s Digital Health Market Assessment
Nexdigm assessed 6 digital-health models across 4 markets, comparing adoption, reimbursement, competitive intensity, regulation and monetization.
The assessment prioritized 2 models for further expansion and mapped the provider, payer and technology partnerships required to support commercialization.
Digital health ultimately scales when adoption, economics, clinical integration and market conditions reinforce one another.
Nexdigm’s digital health market assessment helps companies evaluate those variables together, distinguishing scalable business models from solutions that may have strong technology but limited commercial pathways.
To take the next step, simply visit our Request a Consultation page and share your requirements with us.
Harsh Mittal
+91-8422857704
[email protected]